CSIMarket
 
Mylan N v   (NASDAQ: MYL)
 

Mylan N V's Customers Performance

MYL



 
MYL's Source of Revenues During the corresponding time, Mylan N V recorded a revenue increase by 0.35 % year on year, sequentially revenue grew by 8.82 %. While revenue at the Mylan N V 's corporate clients

List of MYL Customers




for the same period Mylan N V recorded revenue increase by 0.35 % year on year, sequentially revenue grew by 8.82 %.

List of MYL Customers

Mylan N V's Business Units






Mylan N V's Comment on Sales, Marketing and Customers



Generics Segment
In North America, we market products directly to wholesalers, distributors, retail pharmacy chains, long-term care facilities, mail order pharmacies and GPOs. We also market our generic products indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, pharmacy benefit management companies and government entities. These customers, called “indirect customers,” purchase our products primarily through our wholesale customers. In North America, wholesalers and retail drug chains have undergone, and are continuing to undergo, significant consolidation, which may result in these groups gaining additional purchasing leverage.

19
Table of Contents


In EMEA and the Rest of World, generic pharmaceuticals are sold to wholesalers, independent pharmacies and, in certain countries, directly to hospitals. Through a broad network of sales representatives, we adapt our marketing strategy to the different markets as dictated by their respective regulatory and competitive landscapes. Our API are sold primarily to generic FDF manufacturers throughout the world, as well as to other Mylan subsidiaries.

Specialty Segment
Mylan Specialty markets its products to a number of different customer audiences in the U.S., including health care practitioners, wholesalers, pharmacists and pharmacy chains, hospitals, payers, pharmacy benefit manager, health maintenance organizations (“HMOs”), home health care, long-term care and patients. We reach these customers through our field-based sales force and National Accounts team of approximately 370 employees, to increase our customers’ understanding of the unique clinical characteristics and benefits of our branded products. Additionally, Mylan Specialty supports educational programs to consumers and patients.

Major Customers
Sales to Cardinal Health, Inc. represented approximately 15%, of consolidated net revenues.

Sales to McKesson Corporation represented approximately 14%, of consolidated net revenues.

Consistent with industry practice, we have a return policy that allows our customers to return product within a specified period prior to and subsequent to the expiration date.